OVERVIEW

Heart Failure Guidelines: New Treatment Options is Organized by American Association of Critical - Care Nurses (AACN) and would be held during Sep 14, 2017 - Sep 14, 2020. This CME Conference has been approved with a maximum of 1.00 Contact Hours

Webinar Summary:
The number of patients with heart failure continues to increase so staying current on this topic is essential, regardless of your practice setting. In this webinar, Cheryl Westlake, who represented nurses on the committee that authored “Guideline for the Management of Heart Failure,” will describe the changes made in the 2017 focused update. These changes include new treatment options for patients with stage-C heart failure with reduced ejection fraction (HFrEF). Because of her unique experience, Westlake will provide a brief overview of the guideline writing process, levels of evidence and the classification of recommendations. She will then use a case study to demonstrate application of the heart failure guidelines to patient care. The use of biomarkers to diagnose heart failure and to identify patients at risk for poor outcomes will be described. Medical management of stage-C HFrEF will also be discussed, including the use of angiotensin receptor- neprilysin inhibitors (ARNIs), a new class of medications that has shown positive effects in recent clinical trials.

Conference Topics are:
• Cardiovascular
• Pharmacology
• Hemodynamics.

Conferences Objectives:
• Identify biomarkers that are useful in diagnosing heart failure and identifying patients at risk for poor outcomes
• Describe evidence-based medical management of stage C heart failure with reduced ejection fraction
• Apply recommendations from Guidelines for the Management of Heart Failure to patient care situations

Additional details will be posted as soon as they are available.